Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06163040
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-11-30
Brief Title:
A Study to Evaluate the Safety of Empliciti Elotuzumab When Treating Patients With Multiple Myeloma in Taiwan
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Relapsed or Refractory Multiple Myeloma |
Keywords: